Researchers in the US have started what is the country’s first double-blind, randomized, placebo-controlled study examining the effect of cannabis products on severe migraine symptoms.
Recreational cannabis use is currently legal in 16 states including Washington DC, while another 37 states have legalized the drug for medical use. Both Virginia and New Mexico are expected to follow suit, but the changes to their legislation will not be in effect until this summer. Although numerous states across the US have taken a dovish stance on marijuana use as of recent, research into the effects of cannabis-derived THC and CBD have yet to gain any meaningful traction.
However, it appears that researchers at the University of California San Diego (UCSD) School of Medicine have initiated the first step, and recently started the first clinical trials testing the efficacy of cannabis products on individuals suffering from acute migraines. As of current, the researchers are running the trial with 20 participants who suffer from frequent migraines, though they anticipate to increase the sample size by an additional 70 volunteers in the foreseeable future.
For those that suffer from acute migraines, the symptoms can be extenuating, with pain lasting for hours and sometimes even days. Meanwhile, other suffers must deal with a plethora of additional negative symptoms, including nausea, vomiting, and even extreme sensitivity to light or sound. Although numerous treatment options are available, those suffering from reoccurring migraines are still having difficulty finding effective relief using traditional medical or pharmaceutical interventions.
Published: May 24, 2021
Founder & Interim Editor of L.A. Cannabis News